Submitted by Anonymous (not verified) on 18 November 2025 - 15:18
Human medicines European public assessment report (EPAR): Efavirenz/Emtricitabine/Tenofovir disoproxil Mylan, efavirenz,emtricitabine,tenofovir disoproxil, Date of authorisation: 05/09/2017, Revision: 18, Status: Authorised
Source: